BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$85.60+0.56 (+0.66%)
Close on Nov 13, 2026Market cap $21.50BP/E –Yield –
BioNTech total assets
Total assets on the balance sheet at the end of each period.
BioNTech's total assets was €21.99B at Dec 31, 2025. For fiscal 2025 it was €21.99B, down 2.4% from the year before. The highest annual figure on record is €23.28B in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €21.99B | -2.4% |
| FY2024 | Dec 31, 2024 | €22.53B | -2.1% |
| FY2023 | Dec 31, 2023 | €23.01B | -1.2% |
| FY2022 | Dec 31, 2022 | €23.28B | +47.0% |
| FY2021 | Dec 31, 2021 | €15.83B | +582.8% |
| FY2020 | Dec 31, 2020 | €2.32B | +190.7% |
| FY2019 | Dec 31, 2019 | €797.65M | +22.2% |
| FY2018 | Dec 31, 2018 | €652.99M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | €21.99B | +38.9% |
| Q4 FY2024 | Dec 31, 2024 | €22.53B | +871.7% |
| Q4 FY2023 | Dec 31, 2023 | €23.01B | +2784.3% |
| Q4 FY2022 | Dec 31, 2022 | €23.28B | +3465.0% |
| Q4 FY2021 | Dec 31, 2021 | €15.83B | – |
| Q4 FY2020 | Dec 31, 2020 | €2.32B | – |
| Q4 FY2019 | Dec 31, 2019 | €797.65M | – |
| Q4 FY2018 | Dec 31, 2018 | €652.99M | – |
See a number that looks wrong?